Cargando…
Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
Blockade of tumour necrosis factor (TNF) is an effective treatment in rheumatoid arthritis (RA), but both non-responders and partial responders are quite frequent. This suggests that other pro-inflammatory cytokines may be of importance in the pathogenesis of RA and as possible targets for therapy....
Autores principales: | Ernestam, Sofia, af Klint, Erik, Catrina, Anca Irinel, Sundberg, Erik, Engström, Marianne, Klareskog, Lars, Ulfgren, Ann-Kristin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526582/ https://www.ncbi.nlm.nih.gov/pubmed/16507118 http://dx.doi.org/10.1186/ar1871 |
Ejemplares similares
-
Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004) -
Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2005) -
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
por: Lindberg, Johan, et al.
Publicado: (2006) -
Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients – a prospective clinical study
por: Sundberg, Erik, et al.
Publicado: (2008) -
Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology
por: Lindberg, Johan, et al.
Publicado: (2006)